Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Department of Psychiatry, WHO Collaborating Centre in Mental Health Research and Capacity-Building, School of Medicine, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
PLoS One. 2021 Jan 20;16(1):e0238137. doi: 10.1371/journal.pone.0238137. eCollection 2021.
Evidence from high-income countries demonstrates that co-morbid mental disorders in people with epilepsy adversely affect clinical and social outcomes. However, evidence from low-income countries is lacking. The objective of this study was to measure the association between co-morbid mental disorders and quality of life and functioning in people with epilepsy.
A facility-based, community ascertained cross-sectional survey was carried out in selected districts of the Gurage Zone, Southern Ethiopia. Participants were identified in the community and referred to primary health care (PHC) clinics. Those diagnosed by PHC workers were recruited. Co-morbid mental disorders were measured using a standardised, semi-structured clinical interview administered by mental health professionals. The main outcome, quality of life, was measured using the Quality of Life in Epilepsy questionnaire (QOLIE-10p). The secondary outcome, functional disability, was assessed using the 12-item World Health Organization Disability Assessment Schedule (WHODAS-2).
The prevalence of comorbid mental disorders was 13.9%. Comorbid mental disorders were associated with poorer quality of life (Adjusted (Adj.) β -13.27; 95% CI -23.28 to-3.26) and greater disability (multiplier of WHODAS-2 score 1.62; 95% CI 1.05, 2.50) after adjusting for hypothesised confounding factors. Low or very low relative wealth (Adj. β = -12.57, 95% CI -19.94 to-5.20), higher seizure frequency (Adj.β coef. = -1.92, 95% CI -2.83 to -1.02), and poor to intermediate social support (Adj. β coef. = -9.66, 95% CI -16.51 to -2.81) were associated independently with decreased quality of life. Higher seizure frequency (multiplier of WHODAS-2 score 1.11; 95% CI 1.04, 1.19) was associated independently with functional disability.
Co-morbid mental disorders were associated with poorer quality of life and impairment, independent of level of seizure control. Integrated and comprehensive psychosocial care is required for better health and social outcomes of people with epilepsy.
来自高收入国家的证据表明,癫痫患者的合并精神障碍会对临床和社会结局产生不利影响。然而,来自低收入国家的证据尚不足。本研究旨在测量合并精神障碍与癫痫患者的生活质量和功能之间的关联。
在埃塞俄比亚古拉格地区的选定地区进行了一项基于医疗机构、社区确认的横断面调查。在社区中确定参与者,并将其转介到初级保健(PHC)诊所。由 PHC 工作人员诊断的患者被招募。使用由心理健康专业人员管理的标准化半结构式临床访谈来测量合并的精神障碍。主要结局(生活质量)使用癫痫生活质量问卷(QOLIE-10p)进行测量。次要结局(功能障碍)使用 12 项世界卫生组织残疾评估量表(WHODAS-2)进行评估。
合并精神障碍的患病率为 13.9%。合并精神障碍与较差的生活质量相关(调整后的(Adj.)β值为-13.27;95%置信区间(CI)为-23.28 至-3.26),并且在调整了假设的混杂因素后,与更大的残疾相关(WHODAS-2 评分的乘数为 1.62;95%CI 为 1.05,2.50)。相对财富水平低或极低(Adj.β=-12.57;95%CI-19.94 至-5.20)、更高的癫痫发作频率(Adj.β值为-1.92;95%CI-2.83 至-1.02)和较差至中等的社会支持(Adj.β值为-9.66;95%CI-16.51 至-2.81)与生活质量下降独立相关。更高的癫痫发作频率(WHODAS-2 评分的乘数为 1.11;95%CI 为 1.04 至 1.19)与功能障碍独立相关。
合并精神障碍与生活质量和功能障碍有关,与癫痫发作控制水平无关。需要进行综合的心理社会护理,以改善癫痫患者的健康和社会结局。